Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>

Uloženo v:
Podrobná bibliografie
Hlavní autor: Subhamoy Chakraborty (16648124) (author)
Další autoři: Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author)
Vydáno: 2025
Témata:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Lung Cancer
Preclinical Models
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky